ADAG – adagene inc. - ads, each representing 1.25 ordinary shares (US:NASDAQ)
Stock Stats
News
ACROBiosystems Powers Innovation at bioSeedin's JPM Spotlight, Strategically Supporting Global Partnership Forging
Adagene Provides Business Update and 2026 Objectives
Adagene Announces FDA Fast Track Designation for Muzastotug (ADG126)
Adagene (NASDAQ:ADAG) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Adagene (NASDAQ:ADAG) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Form SCHEDULE 13G/A Adagene Inc. Filed by: Smith Vincent C
Form 6-K Adagene Inc. For: Jan 23
Form EFFECT Adagene Inc.
Form 424B3 Adagene Inc.
Form SCHEDULE 13G/A Adagene Inc. Filed by: WuXi PharmaTech Healthcare Fund I L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.